Real-life evaluation of the 2017 McDonald criteria for relapsing-remitting multiple sclerosis after a clinically isolated syndrome confirms a gain in time-to-diagnosis.

Fiche publication

Date publication

août 2023

Journal

Journal of neurology

Auteurs

Membres identifiés du Cancéropôle Est :
Pr GUILLEMIN Francis

Tous les auteurs :
Ferrand M, Epstein J, Soudant M, Guillemin F, Pittion-Vouyovitch S, Debouverie M, Mathey G

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/37650895

Résumé

Previous cohort studies evaluating the performances of the McDonald criteria suffered from bias regarding real-life conditions. We aimed to evaluate the probability of diagnosing relapsing-remitting multiple sclerosis (MS) at several timepoints from the first medical evaluation and the gain in time-to-diagnosis with the 2017 McDonald criteria compared with the 2001, 2005 and 2010 versions in real life.